EVENTIDE ASSET MANAGEMENT, LLC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1442891 Boston, MA

Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$23,842,546

+$2,798,530 QoQ

Shares Held

1,327,536

-12.3% QoQ

Ownership

1.19%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#19

of 207 holders

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

EVENTIDE ASSET MANAGEMENT, LLC holds $88,407,691 across 4 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (27.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COLL	Collegium Pharmaceutical, Inc	1,361,228	$49,276,453
2	AMLX	Amylyx Pharmaceuticals, Inc. This page	1,327,536	$23,842,546
3	UTHR	UNITED THERAPEUTICS Corp	27,101	$14,684,134
4	ZTS	Zoetis Inc.	8,413	$604,558

All Filings in AMLX

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,842,546	1,327,536	-12.3%	Shares	Sole	2026-08-14
2026-03-31	$21,044,016	1,513,958	+0.1%	Shares	Sole	2026-05-15
2025-12-31	$18,278,827	1,513,148	+0.0%	Shares	Sole	2026-02-13
2025-09-30	$20,554,875	1,512,500	+35.4%	Shares	Sole	2025-11-14
2023-12-31	$16,439,840	1,116,837	0.0%	Shares	Sole	2024-02-20
2023-09-30	$20,449,285	1,116,837	0.0%	Shares	Sole	2023-11-14
2023-06-30	$24,090,174	1,116,837	+143.8%	Shares	Sole	2023-08-15
2023-03-31	$13,439,304	458,054	+83.2%	Shares	Sole	2023-05-15
2022-12-31	$9,237,500	250,000	—	Shares	Sole	2023-02-13
No filing history on record for this holder in this stock.